Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
98.8 PLN | -1.79% | -2.76% | +3.02% |
Sales 2024 * | 2.33B 575M | Sales 2025 * | 2.55B 628M | Capitalization | 2B 492M |
---|---|---|---|---|---|
Net income 2024 * | 48M 11.83M | Net income 2025 * | 179M 44.11M | EV / Sales 2024 * | 1.08 x |
Net Debt 2024 * | 533M 131M | Net Debt 2025 * | 472M 116M | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
41.2
x | P/E ratio 2025 * |
12.2
x | Employees | 1,446 |
Yield 2024 * |
3.73% | Yield 2025 * |
5.22% | Free-Float | 15.74% |
1 day | -1.79% | ||
1 week | -2.76% | ||
Current month | -4.45% | ||
1 month | -5.18% | ||
3 months | +3.13% | ||
6 months | +6.58% | ||
Current year | +3.02% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 98-12-31 | |
Robert Pabich
BRD | Director/Board Member | - | 14-11-11 |
Marlena Matusiak
IRC | Investor Relations Contact | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 93-12-31 | |
Alfred Pelzer
CHM | Chairman | 65 | - |
Director/Board Member | - | 04-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 98.8 | -1.79% | 1 862 |
24-04-18 | 100.6 | +0.40% | 793 |
24-04-17 | 100.2 | -0.40% | 1,644 |
24-04-16 | 100.6 | 0.00% | 2,970 |
24-04-15 | 100.6 | -0.98% | 1,298 |
Delayed Quote Warsaw S.E., April 19, 2024 at 06:06 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.02% | 492M | |
+10.52% | 62.67B | |
-6.21% | 45.97B | |
+12.51% | 39.51B | |
+17.90% | 26.04B | |
+0.44% | 17.71B | |
+5.68% | 15.44B | |
-27.99% | 14.54B | |
-22.62% | 13.14B | |
-23.93% | 13.09B |
- Stock Market
- Equities
- PCR Stock